71 related articles for article (PubMed ID: 12792810)
21. Over-expression of Id-1 induces cell proliferation in hepatocellular carcinoma through inactivation of p16INK4a/RB pathway.
Lee TK; Man K; Ling MT; Wang XH; Wong YC; Lo CM; Poon RT; Ng IO; Fan ST
Carcinogenesis; 2003 Nov; 24(11):1729-36. PubMed ID: 12949053
[TBL] [Abstract][Full Text] [Related]
22. High concentrations of recombinant adenovirus expressing p16 gene induces apoptosis in lung cancer cell lines.
Naruse I; Heike Y; Hama S; Mori M; Saijo N
Anticancer Res; 1998; 18(6A):4275-82. PubMed ID: 9891478
[TBL] [Abstract][Full Text] [Related]
23. [Exogenous mtsl/p16 gene suppresses tumorigenicity of human gastric cancer cell line].
Sun M; Lu Y
Zhonghua Zhong Liu Za Zhi; 1997 Nov; 19(6):410-3. PubMed ID: 10920869
[TBL] [Abstract][Full Text] [Related]
24. [Construction of a eukaryotic vector expressing E2F-1 Gene and its effect on proliferation of gastric cancer cell line MKN-45].
Wang CQ; Xiao Q; Li L; Xie YB; Tan N; Gong ZW
Ai Zheng; 2007 Oct; 26(10):1064-8. PubMed ID: 17927874
[TBL] [Abstract][Full Text] [Related]
25. Expression of thymidylate synthase, thymidine phosphorylase, dihydropyrimidine dehydrogenase, E2F-1, Bak, Bcl-X, and Bcl-2, and clinical outcomes for gastric cancer patients treated with bolus 5-fluorouracil.
Tahara M; Ochiai A; Fujimoto J; Boku N; Yasui W; Ohtsu A; Tahara E; Yoshida S
Oncol Rep; 2004 Jan; 11(1):9-15. PubMed ID: 14654896
[TBL] [Abstract][Full Text] [Related]
26. [Effects of extracellular signal-regulated kinase/mitogen-activated protein kinase signaling pathway activation on proliferation and cell cycle associated genes in human colon cancer cells].
Wang X; Lu R; Fang JY
Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(14):982-6. PubMed ID: 17650425
[TBL] [Abstract][Full Text] [Related]
27. Hyperphosphorylation of pRb: a mechanism for RB tumour suppressor pathway inactivation in bladder cancer.
Chatterjee SJ; George B; Goebell PJ; Alavi-Tafreshi M; Shi SR; Fung YK; Jones PA; Cordon-Cardo C; Datar RH; Cote RJ
J Pathol; 2004 Jul; 203(3):762-70. PubMed ID: 15221935
[TBL] [Abstract][Full Text] [Related]
28. Re-expression of p16INK4a in mesothelioma cells results in cell cycle arrest, cell death, tumor suppression and tumor regression.
Frizelle SP; Grim J; Zhou J; Gupta P; Curiel DT; Geradts J; Kratzke RA
Oncogene; 1998 Jun; 16(24):3087-95. PubMed ID: 9671387
[TBL] [Abstract][Full Text] [Related]
29. Suppression of U937 human monocytic leukemia cell growth by dideoxypetrosynol A, a polyacetylene from the sponge Petrosia sp., via induction of Cdk inhibitor p16 and down-regulation of pRB phosphorylation.
Park C; Kim GY; Kim GD; Lee WH; Cheong JH; Kim ND; Bae SJ; Jung JH; Choi YH
Oncol Rep; 2006 Jul; 16(1):171-6. PubMed ID: 16786142
[TBL] [Abstract][Full Text] [Related]
30. Prognostic role of E2F1 and members of the CDKN2A network in gastrointestinal stromal tumors.
Haller F; Gunawan B; von Heydebreck A; Schwager S; Schulten HJ; Wolf-Salgó J; Langer C; Ramadori G; Sültmann H; Füzesi L
Clin Cancer Res; 2005 Sep; 11(18):6589-97. PubMed ID: 16166437
[TBL] [Abstract][Full Text] [Related]
31. Macrophage inhibitory cytokine-1 induces the invasiveness of gastric cancer cells by up-regulating the urokinase-type plasminogen activator system.
Lee DH; Yang Y; Lee SJ; Kim KY; Koo TH; Shin SM; Song KS; Lee YH; Kim YJ; Lee JJ; Choi I; Lee JH
Cancer Res; 2003 Aug; 63(15):4648-55. PubMed ID: 12907645
[TBL] [Abstract][Full Text] [Related]
32. Increased E2F-1 expression via tumour cell proliferation and decreased apoptosis are correlated with adverse prognosis in patients with squamous cell carcinoma of the oesophagus.
Yamazaki K; Hasegawa M; Ohoka I; Hanami K; Asoh A; Nagao T; Sugano I; Ishida Y
J Clin Pathol; 2005 Sep; 58(9):904-10. PubMed ID: 16126868
[TBL] [Abstract][Full Text] [Related]
33. Id1 is down-regulated by hepatocyte growth factor via ERK-dependent and ERK-independent signaling pathways, leading to increased expression of p16INK4a in hepatoma cells.
Ushio K; Hashimoto T; Kitamura N; Tanaka T
Mol Cancer Res; 2009 Jul; 7(7):1179-88. PubMed ID: 19567783
[TBL] [Abstract][Full Text] [Related]
34. Expression of retinoblastoma protein and P16 proteins in classic Hodgkin lymphoma: relationship with expression of p53 and presence of Epstein-Barr virus in the regulation of cell growth and death.
Kim LH; Peh SC; Poppema S
Hum Pathol; 2006 Jan; 37(1):92-100. PubMed ID: 16360421
[TBL] [Abstract][Full Text] [Related]
35. p53, p21, pRB, and p16 expression predict clinical outcome in cystectomy with bladder cancer.
Shariat SF; Tokunaga H; Zhou J; Kim J; Ayala GE; Benedict WF; Lerner SP
J Clin Oncol; 2004 Mar; 22(6):1014-24. PubMed ID: 14981102
[TBL] [Abstract][Full Text] [Related]
36. 5-Bromo-2-deoxyuridine activates DNA damage signalling responses and induces a senescence-like phenotype in p16-null lung cancer cells.
Masterson JC; O'Dea S
Anticancer Drugs; 2007 Oct; 18(9):1053-68. PubMed ID: 17704656
[TBL] [Abstract][Full Text] [Related]
37. p14ARF protein expression is a predictor of both relapse and survival in squamous cell carcinoma of the anterior tongue.
Kwong RA; Kalish LH; Nguyen TV; Kench JG; Bova RJ; Cole IE; Musgrove EA; Sutherland RL
Clin Cancer Res; 2005 Jun; 11(11):4107-16. PubMed ID: 15930346
[TBL] [Abstract][Full Text] [Related]
38. p16/MTS1/INK4A suppresses prostate cancer by both pRb dependent and independent pathways.
Steiner MS; Wang Y; Zhang Y; Zhang X; Lu Y
Oncogene; 2000 Mar; 19(10):1297-306. PubMed ID: 10713671
[TBL] [Abstract][Full Text] [Related]
39. AP-1 blockade in breast cancer cells causes cell cycle arrest by suppressing G1 cyclin expression and reducing cyclin-dependent kinase activity.
Liu Y; Lu C; Shen Q; Munoz-Medellin D; Kim H; Brown PH
Oncogene; 2004 Oct; 23(50):8238-46. PubMed ID: 15378019
[TBL] [Abstract][Full Text] [Related]
40. The inhibitor of cyclin-dependent kinase 4a/alternative reading frame (INK4a/ARF) locus encoded proteins p16INK4a and p19ARF repress cyclin D1 transcription through distinct cis elements.
D'Amico M; Wu K; Fu M; Rao M; Albanese C; Russell RG; Lian H; Bregman D; White MA; Pestell RG
Cancer Res; 2004 Jun; 64(12):4122-30. PubMed ID: 15205322
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]